NYMOX PHARM CORP (NYMXF) Stock Price, Quote & AI Analysis
Live NYMXF stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for NYMOX PHARM CORP.
TradeVae provides AI-driven analysis and real-time market intelligence for NYMOX PHARM CORP (NYMXF), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
NYMOX PHARM CORP's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
NYMOX PHARM CORP Overview
Company information
Company Overview
Nymox Pharmaceutical Corp. engages in the research and development of products for the aging population. Its products include NicAlert, TobacAlert and Fexapotide Triflutate for the treatment of low-grade localized prostate cancer. The company was founded by Paul Averback on May 30, 1995 and is headquartered in Nassau, the Bahamas.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
NYMOX PHARM CORP Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...